We Bring The Lab Into The Home
Point-of-Care (POC) Lab-on-Chip (LOC) device solution for Chronic Kidney Disease management and assessment.
Finance and Healthcare Professionals
Lab-On-Chip Platform Technology for Chronic Disease Diagnosis
Patent Pending Device for Rapid Testing of Chronic Kidney Disease
Virtual Care Platform for Continued Disease Management
We are a TSX Venture listed reporting issuer and intend to use this public entity to raise the necessary capital to advance and commercialize our first device for Chronic Kidney Disease point-of-care diagnosis and a virtual continued care and education platform for disease management.
We Are Healthcare and Finance Professionals
My Health Logic is solely focused on the Development and Commercialization of its Microfluidic Lab-on-Chip Technology and MATLOC Diagnostic Device for Point-of-Care Digital Assessment and Data Management.
Chronic Kidney Disease
Chronic KIdney Desase (CKD) or Chronic Renal Desease (CRD) means your kidneys are damaged and loosing their ability to keep you healthy
1 in 7 American adults are estimated to have CKD. It is the 9th leading cause of death in the U.S.
In Medicare costs, 2017, for all people with all stages of CKD.
Of people who have CKD don’t know they have it.
Dr. Claudio Rigatto is a Kidney Disease specialist and Associate Professor of Medicine at the University of Manitoba, as well as the Academic Director of the Chronic Disease Innovation Centre. He has developed POC tests (with Dr Lin) for early detection and risk prediction in CKD, as well as tablet based tools to monitor patient health status at home (telemonitoring).
George was most recently Vice President Finance at Phivida Holdings Inc (VIDA: CSE), a publicly traded company that has raised over $19 million since its IPO in December 2017. He has spent 11 years as an experienced financial controller, working on public companies audits and financial statements to GAAP and IFRS.
Zachary is a corporate finance and advisory professional, specializing in taking companies public. Mr. Stadnyk is currently the Chief Executive Officer and a Director of DC Acquisition Corp
Dr. Francis Lin is the lead inventor of Health Logic’s lab-on-chip technology. Dr. Lin joined the University of Manitoba and is currently a tenured Full Professor in Physics, Immunology and Biological Sciences.
A physician scientist with expertise in clinical nephrology, CKD, health economics, and health systems design.
Dr. Wu’s research focuses on developing microfluidic chips and systems for in vitro cell migration studies and in vitro diagnostics.
Dr. Susy Santos is a diversely experienced leader in healthcare. She is a highly qualified strategic decision-maker in overseeing operations in both clinical and community health services.